Skip to main content
. 2020 Feb 11;2020(2):CD004863. doi: 10.1002/14651858.CD004863.pub6

1.46. Analysis.

1.46

Comparison 1 Erythropoietin versus placebo or no treatment, Outcome 46 Survival without major neurological or neurodevelopmental disorders at 2 years of age.